Dankovtseva E N, Zateĭshchikov D A, Sidorenko B A
Presidential Medical Center of Russia; ul. Marshala Timoshenko, 15, 121356 Moscow, Russia.
Kardiologiia. 2006;46(2):56-65.
The review is devoted to analysis of data, related to contribution of genetic peculiarities of the hemostasis system to early development of ischemic heart disease (IHD). Information is presented on polymorphisms of tissue factor, coagulation factors VII, V, prothrombin, thrombomodulin, fibrinogen, thrombin activated fibrinolysis inhibitor, tissue plasminogen activator inhibitor, platelet membrane glycoproteines Ia, Iba, IIIa in patients with early development of IHD. Contradictoriness of existing data on effects of genetic heterogeneity of factors of hemostasis on risk of development of IHD at young age and necessity of further investigations in this area are underlined.
本综述致力于分析与止血系统遗传特性对缺血性心脏病(IHD)早期发展的贡献相关的数据。文中介绍了IHD早期发病患者中组织因子、凝血因子VII、V、凝血酶原、血栓调节蛋白、纤维蛋白原、凝血酶激活的纤溶抑制物、组织型纤溶酶原激活物抑制剂、血小板膜糖蛋白Ia、Iba、IIIa的多态性。强调了现有关于止血因子遗传异质性对年轻时IHD发病风险影响的数据存在矛盾性,以及该领域进一步研究的必要性。